Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients
- 21 April 2006
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 22 (6) , 1045-1064
- https://doi.org/10.1185/030079906x104623
Abstract
Background: Bone disease is a serious complication of Gaucher disease. Untreated, it can result in pain, permanent bone damage and disability. Enzyme replacement therapy reverses many of the clinical signs of Gaucher bone disease but early assessment and treatment, and regular monitoring, are essential in optimising outcomes.Scope: In September 2005, a group of European experts met to review current knowledge and identify best practice and unmet needs in the monitoring of Gaucher bone disease and the response to enzyme replacement therapy.Methods: Medline searches of peer-reviewed literature (no date restrictions) were conducted and supplemented by additional information considered relevant by panellists to furthering discussions.Findings and conclusions: The group's recommendations included: currently used biochemical bone markers are not clinically practical or reliable; plain X‐rays should not be the sole method of assessing bone disease; MRI is the most sensitive method for monitoring bone mar...Keywords
This publication has 78 references indexed in Scilit:
- Enzyme replacement therapy for Gaucher disease in AustraliaInternal Medicine Journal, 2005
- Bone density changes with enzyme therapy for Gaucher diseaseJournal of Bone and Mineral Metabolism, 2004
- Gaucher disease and bone: Laboratory and skeletal mineral density variations during a long period of enzyme replacement therapyJournal of Inherited Metabolic Disease, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Novel strategies for the treatment of osteoarthritisExpert Opinion on Investigational Drugs, 2000
- Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10QJM: An International Journal of Medicine, 1997
- Scintigraphic findings on99mTc-MDP,99mTc-sestamibi and99mTc-HMPAO images in Gaucher's diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Markers of bone metabolismCurrent Opinion in Rheumatology, 1995
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphyAmerican Journal of Roentgenology, 1986